News
Gene therapy appears to be a promising approach for a subset of genetic deafness, although challenges remain with development ...
But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...
Findings from St. Jude Children's Research Hospital demonstrate that virtual memory T cells, a specialized group of immune ...
Ixo-vec reduced anti-VEGF injection frequency and was well tolerated in patients with wet AMD. A phase 3 pivotal trial ...
Over a whirlwind three weeks, Sarepta Therapeutics has faced tough safety questions around its commercial gene therapy ...
The CMS said on Wednesday that 33 states, plus the District of Columbia and Puerto Rico, will participate in the “Cell and Gene Therapy Access Model” to centrally coordinate insurance coverage ...
For nearly three decades, Mayo Clinic researcher Christopher Evans, Ph.D., has pushed to expand gene therapy beyond its ...
The primary safety risks associated with gene therapy include immune reactions and off-target effects in unintended organs, such as the liver, lungs, and spleen. Nevertheless, Ali and Townsend note ...
News-Medical.Net on MSN3d
Single injection of gene therapy at birth may offer lasting protection against HIV
A new study in Nature shows that delivering a single injection of gene therapy at birth may offer years-long protection ...
Leveraging Northway Biotech’s 20+ years of CDMO expertise, Diorasis Therapeutics is advancing AAV gene therapy for glaucoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback